Item 7.01 Regulation FD Disclosure.

On November 22, 2021, Keros Therapeutics, Inc. (the "Company") issued a press release announcing that Jasbir Seehra, the Company's President and Chief Executive Officer, will present at the Piper Sandler 33rd Annual Virtual Healthcare Conference. A recording of the fireside chat presentation will be available starting on Monday, November 22, 2021 at 10:00 am ET. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.




Item 9.01   Financial Statements and Exhibits.
(d) Exhibits

Exhibit No.                    Description
  99.1                           Press release dated November     22    , 2021.
                               Cover Page Interactive Data File (the cover page XBRL tags are
104                            embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses